Number of the records: 1
Antiviral activity of GS-5801, a liver-targeted prodrug of a lysine demethylase 5 inhibitor, in a hepatitis B virus primary human hepatocyte infection model
SYS 0478230 LBL 01000a^^22220027750^450 005 20240103214529.0 014 $a 000401056601696 $2 WOS 017 70
$a 10.1016/S0168-8278(17)31855-X $2 DOI 100 $a 20170920d m y slo 03 ba 101 0-
$a eng 102 $a NL 200 1-
$a Antiviral activity of GS-5801, a liver-targeted prodrug of a lysine demethylase 5 inhibitor, in a hepatitis B virus primary human hepatocyte infection model 215 $a 2 s. $c P 463 -1
$1 001 cav_un_epca*0256979 $1 011 $a 0168-8278 $e 1600-0641 $1 200 1 $a Journal of Hepatology $v Roč. 66, Suppl 1 (2017), s. 690-691 $1 210 $c Elsevier 608 $a Meeting Abstract 610 $a GS-5801 610 $a liver 610 $a hepatitis B virus 700 -1
$3 cav_un_auth*0350012 $4 070 $a Gilmore $b S. $y US $z K 701 -1
$3 cav_un_auth*0350013 $4 070 $a Tam $b D. $y US 701 -1
$3 cav_un_auth*0350014 $4 070 $a Dick $b R. $y US 701 -1
$3 cav_un_auth*0350015 $4 070 $a Appleby $b T. $y US 701 -1
$3 cav_un_auth*0103441 $i Vyléčení hepatitidy B $j HBV Cure $k 790/79 $l 790/79 $w Molecular interactions in biomedicine $4 070 $a Birkuš $b Gabriel $p UOCHB-X $T Ústav organické chemie a biochemie AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0350016 $4 070 $a Willkom $b M. $y US 701 -1
$3 cav_un_auth*0350017 $4 070 $a Delaney $b W. E. $y US 701 -1
$3 cav_un_auth*0350018 $4 070 $a Notte $b G. T. $y US 701 -1
$3 cav_un_auth*0350019 $4 070 $a Feierbach $b B. $y US
Number of the records: 1